为制备猪δ冠状病毒(PDCoV)N蛋白的特异性单克隆抗体,并初步应用于临床样品中PDCoV抗原的免疫组织化学(IHC)检测,本研究以原核表达的PDCo V N蛋白免疫BALB/c小鼠,取其脾细胞与骨髓瘤细胞进行融合,基于纯化的N蛋白建立的间接ELISA方法筛...为制备猪δ冠状病毒(PDCoV)N蛋白的特异性单克隆抗体,并初步应用于临床样品中PDCoV抗原的免疫组织化学(IHC)检测,本研究以原核表达的PDCo V N蛋白免疫BALB/c小鼠,取其脾细胞与骨髓瘤细胞进行融合,基于纯化的N蛋白建立的间接ELISA方法筛选获得稳定分泌N蛋白特异性单克隆抗体的杂交瘤细胞,并对单克隆抗体的免疫反应特异性、亚类进行系统鉴定。结果显示:通过3次亚克隆筛选获得8株可分泌PDCo V N蛋白单克隆抗体的杂交瘤细胞株。经IFA和Western blot分析,证实制备的单克隆抗体均与猪δ冠状病毒反应,且不与猪流行性腹泻病毒(PEDV)和猪传染性胃肠炎病毒(TGEV)反应,特异性良好。单克隆抗体亚类鉴定结果表明,1A11、3C6、1E7、1E12株单克隆抗体属Ig G1型,4F3、2A3株单克隆抗体为Ig G2a型,3E4单克隆抗体为Ig M型,8株单克隆抗体的轻链均为κ链。利用1A11单克隆抗体对PDCo V、PDEV、TGEV感染猪的空肠、回肠组织进行IHC检测,结果表明1A11能与感染PDCo V的组织发生特异性免疫反应,而不与感染PDEV和TGEV的组织发生反应,特异性良好。本研究制备的PDCo V N蛋白单克隆抗体可为PDCo V诊断方法的建立以及N蛋白的功能研究奠定基础。展开更多
Cholesterol represents one of the key constituents of small,dynamic,sterol-and sphingolipid-enriched domains on the plasma membrane.It has been reported that many viruses depend on plasma membrane cholesterol for effi...Cholesterol represents one of the key constituents of small,dynamic,sterol-and sphingolipid-enriched domains on the plasma membrane.It has been reported that many viruses depend on plasma membrane cholesterol for efficient infection.In this study,the role of the plasma membrane cholesterol in porcine reproductive and respiratory syndrome virus(PRRSV) infection of MARC-145 cells was investigated.Pretreatment of MARC-145 cells with methyl-β-cyclodextrin(MβCD),a drug used to deplete cholesterol from cellular membrane,significantly reduced PRRSV infection in a dose-dependent manner.This inhibition was partially reversed by supplementing exogenous cholesterol following MβCD treatment,suggesting that the inhibition of PRRSV infection was specifically mediated by removal of cellular cholesterol.Further detailed studies showed that depletion of cellular membrane cholesterol significantly inhibited virus entry,especially virus attachment and release.These results indicate that the presence of cholesterol in the cellular membrane is a key component of PRRSV infection.展开更多
Pseudorabies virus(PRV),an alpha-herpesvirus,has been developed as a live viral vector for animal vaccines.However,the PRV recombinant virus TK^(-)/gE^(-)/GP5^(+)expressing GP5 of porcine reproductive and respiratory ...Pseudorabies virus(PRV),an alpha-herpesvirus,has been developed as a live viral vector for animal vaccines.However,the PRV recombinant virus TK^(-)/gE^(-)/GP5^(+)expressing GP5 of porcine reproductive and respiratory syn-drome virus(PRRSV),based on the PRV genetically depleted vaccine strain TK^(-)/gE^(-)/LacZ^(+),scarcely stimulated the vaccinated animals to produce neutralizing antibodies against PRRSV.To develop a booster-specific immune response of such PRV recombinants,the ORF5m gene(the modified ORF5 gene having better immune responses)was substituted for the ORF5 gene and introduced into PRV TK^(-)/gE^(-)/LacZ^(+),resulting in a PRV recombinant named TK^(-)/gE^(-)/GP5m^(+),which expressed the modified GP5m protein.The recombinant virus was confirmed using PCR,Southern blotting and Western blotting.TK^(-)/gE^(-)/GP5m^(+)and TK^(-)/gE^(-)/GP5^(+)expressing the authentic GP5 protein were inoculated into Balb/c mice to evaluate their immune responses.The results indicated that the protecting neutralization antibodies(the 3/6 vaccinated mice obtained 1:16)and cell immune responses induced by TK^(-)/gE^(-)/GP5m^(+)against PRRSV were higher than that induced by TK^(-)/gE^(-)/GP5^(+).Thus,the development of the new PRV recombinant expressing the modified GP5m protein as a candidate vaccine established the basis for the study of bivalent genetic engineering vaccines against PRRSV and PRV.展开更多
文摘为制备猪δ冠状病毒(PDCoV)N蛋白的特异性单克隆抗体,并初步应用于临床样品中PDCoV抗原的免疫组织化学(IHC)检测,本研究以原核表达的PDCo V N蛋白免疫BALB/c小鼠,取其脾细胞与骨髓瘤细胞进行融合,基于纯化的N蛋白建立的间接ELISA方法筛选获得稳定分泌N蛋白特异性单克隆抗体的杂交瘤细胞,并对单克隆抗体的免疫反应特异性、亚类进行系统鉴定。结果显示:通过3次亚克隆筛选获得8株可分泌PDCo V N蛋白单克隆抗体的杂交瘤细胞株。经IFA和Western blot分析,证实制备的单克隆抗体均与猪δ冠状病毒反应,且不与猪流行性腹泻病毒(PEDV)和猪传染性胃肠炎病毒(TGEV)反应,特异性良好。单克隆抗体亚类鉴定结果表明,1A11、3C6、1E7、1E12株单克隆抗体属Ig G1型,4F3、2A3株单克隆抗体为Ig G2a型,3E4单克隆抗体为Ig M型,8株单克隆抗体的轻链均为κ链。利用1A11单克隆抗体对PDCo V、PDEV、TGEV感染猪的空肠、回肠组织进行IHC检测,结果表明1A11能与感染PDCo V的组织发生特异性免疫反应,而不与感染PDEV和TGEV的组织发生反应,特异性良好。本研究制备的PDCo V N蛋白单克隆抗体可为PDCo V诊断方法的建立以及N蛋白的功能研究奠定基础。
基金supported by the National Natural Science Foundation of China (Grant No. 30770082)National Basic Research Program of China (Grant No. 2005CB523200)
文摘Cholesterol represents one of the key constituents of small,dynamic,sterol-and sphingolipid-enriched domains on the plasma membrane.It has been reported that many viruses depend on plasma membrane cholesterol for efficient infection.In this study,the role of the plasma membrane cholesterol in porcine reproductive and respiratory syndrome virus(PRRSV) infection of MARC-145 cells was investigated.Pretreatment of MARC-145 cells with methyl-β-cyclodextrin(MβCD),a drug used to deplete cholesterol from cellular membrane,significantly reduced PRRSV infection in a dose-dependent manner.This inhibition was partially reversed by supplementing exogenous cholesterol following MβCD treatment,suggesting that the inhibition of PRRSV infection was specifically mediated by removal of cellular cholesterol.Further detailed studies showed that depletion of cellular membrane cholesterol significantly inhibited virus entry,especially virus attachment and release.These results indicate that the presence of cholesterol in the cellular membrane is a key component of PRRSV infection.
基金This work was supported by the National Natural Sciences Foundation of China(Grant No.30300257)the National Basic Research Program of China(No.2005CB523200)the Youth Scientist Project of Wuhan City(No.20025001041).
文摘Pseudorabies virus(PRV),an alpha-herpesvirus,has been developed as a live viral vector for animal vaccines.However,the PRV recombinant virus TK^(-)/gE^(-)/GP5^(+)expressing GP5 of porcine reproductive and respiratory syn-drome virus(PRRSV),based on the PRV genetically depleted vaccine strain TK^(-)/gE^(-)/LacZ^(+),scarcely stimulated the vaccinated animals to produce neutralizing antibodies against PRRSV.To develop a booster-specific immune response of such PRV recombinants,the ORF5m gene(the modified ORF5 gene having better immune responses)was substituted for the ORF5 gene and introduced into PRV TK^(-)/gE^(-)/LacZ^(+),resulting in a PRV recombinant named TK^(-)/gE^(-)/GP5m^(+),which expressed the modified GP5m protein.The recombinant virus was confirmed using PCR,Southern blotting and Western blotting.TK^(-)/gE^(-)/GP5m^(+)and TK^(-)/gE^(-)/GP5^(+)expressing the authentic GP5 protein were inoculated into Balb/c mice to evaluate their immune responses.The results indicated that the protecting neutralization antibodies(the 3/6 vaccinated mice obtained 1:16)and cell immune responses induced by TK^(-)/gE^(-)/GP5m^(+)against PRRSV were higher than that induced by TK^(-)/gE^(-)/GP5^(+).Thus,the development of the new PRV recombinant expressing the modified GP5m protein as a candidate vaccine established the basis for the study of bivalent genetic engineering vaccines against PRRSV and PRV.
